Biovica expands Master Services Agreement with a current customer, a leading global pharmaceutical company, to support next-generation oncology development.
Biovica, a company specializing in blood-based cancer monitoring, today announces an expanded Master Services Agreement with a current customer, one of the world’s leading pharmaceutical companies, which has a broad and active oncology pipeline. Under the agreement, Biovica will provide DiviTum® TK…